Abstract:Objective To investigate the cytotoxicity of vascular endothelial growth factor (VEGF) siRNA combined with fusion suicide gene yCDglyTK on human gastric cancer cell line in vitro.Methods The gastric cancer cell line SGC7901 was transfeeted with blank plasmid pcDNA3.1 (-) null [pcDNA3.1 (-) group], or VEGF-siRNA expression plasmid pGenesil-shVEGF (SGC7901/shVEGF group), or fusion suicide gene plasmid pcDNA3.1 (-)CV-yCDglyTK (SGC7901/CDTK group), or combined gene plasmid pcDNA3.1 (-)shVEGF-yCDglyTK (SGC7901//shVEGF-CDTK group) with calcium phosphate nanoparticles (CPNPs).Un-transfected gastric cells were set as control group.The stable transfected cells were selected by G418.The target gene expression was verified by RT-PCR and Western-blot.After given prodrug 5-fluorocytosine (5-FC), the biologic characters variation, apoptotic morphology and apoptotic rate of cells in each group were observed through cell growth curve by MTT assays, by-stander effect, Hoechst 33258 staining and flow cytometry.The data was analyzed with SPSS 13.0 software and multiple groups’ comparison was analyzed with LSD test.Results Four gastric cancer cells lines transfected with different plasmids were successfully established.The expression of gene yCDglyTK was detected both in SGC7901/CDTK cells and SGC7901/shVEGF-CDTK cells.By MTT assays, the cell growth curve indicated that the A570 value of SGC7901/shVEGF cells, SGC7901/CDTK cells and SGC7901/shVEGF-CDTK cells decreased significantly compared with that of SGC7901 and SGC7901/null cells after a 24-hour 5-FC treatment (P＜0.01).When the percentage of stable gene trasfected SGC7901 cells was 60％, 80％and 100％, the cell relative viability was 13.09％±2.40％, 9.74％±2.83％ and 5.68％±1.03％,respectively. A large number of cells in SGC7901/CDTK and SGC7901/shVEGF-CDTK group appeared typical apoptotic morphology under fluorescence microscope.The result of flow cytometry showed that the apoptosis rates in SGC7901/shVEG group、 SGC7901/CDTK group and SGC7901/shVEGF-CDTK group were 16.40％ ±4.68％, 57.63％ ± 4.96％ and 69.07％ ± 4.69％,respectively, and there were significant differences compared with control (P＜0.01).Conclusion VEGF siRNA combined with suicide gene can effectively kill gastric cancer cell line SGC7901.Apoptosis induction may be one of the important mechanisms of killing tumor cells.

Tumor-specific expression of shVEGF and suicide gene as a novel strategy for esophageal cancer therapy.

Combination gene therapy using VEGF-shRNA and fusion suicide gene yCDglyTK inhibits gastric carcinoma growth.

Construction of a Novel Vector Expressing Survivin-shRNA and Fusion Suicide Gene Ycdglytk and Its Application in Inhibiting Proliferation and Migration of Colon Cancer Cells

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Esophageal Squamous Cancers.

Tissue Specific Expression of Suicide Genes Delivered by Nanoparticles Inhibits Gastric Carcinoma Growth

Nanoparticle-delivered VEGF-silencing Cassette and Suicide Gene Expression Cassettes Inhibit Colon Carcinoma Growth in Vitro and in Vivo

Construction of Combination Gene Vector Expressing VEGF-siRNA and Fusion Suicide Gene Ycdglytk and Its Application

The anti tumor effect of vascular endothelial growth factor siRNA combined with yCDglyTK on human gastric cancer in vitro

Novel Non-Viral Vector-Mediated Fusion Suicide Gene Targeted Therapy of Gastric Carcinoma Experimental Study

Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.

Tissue specific cytotoxicity of colon cancer cells mediated by nanoparticle-delivered suicide gene in vitro and in vivo.

Enhanced pancreatic cancer gene therapy by combination of adenoviral vector expressing c-erb-B2 (Her-2=neu)-targeted immunotoxin with a replication-competent adenovirus or etoposide

Tumor-specific transcriptional targeting of suicide gene therapy

Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas

Effective Combination Gene Therapy Using CEACAM6-shRNA and the Fusion Suicide Gene Ycdglytk for Pancreatic Carcinoma in Vitro

Oncolytic adenovirus-mediated dual knockdown of survivin and OCT4 improves therapeutic efficacy in esophageal cancer.

A Novel Fusion Suicide Gene Yeast CDglyTK Plays a Role in Radio-Gene Therapy of Nasopharyngeal Carcinoma

Self-assembled RNA nanocarrier-mediated chemotherapy combined with molecular targeting in the treatment of esophageal squamous cell carcinoma

Construction of carcino-embryonic antigen promotor controls the novel fusion suicide gene yCDglyTK and its application

Effective Gene-Viral Therapy For Telomerase-Positive Cancers By Selective Replicative-Competent Adenovirus Combining With Endostatin Gene

In Vitro And In Vivo Tissue Specific Cytotoxicity Of Gastric Cancer Cells Resulting From Cd:Uprt/5-Fc Gene Therapy System Driven By Htert Promoter